Search alternatives:
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
0 decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
e non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
05 0 » 0 0 (Expand Search), 01 0 (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
0 decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
e non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
05 0 » 0 0 (Expand Search), 01 0 (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Error bars represent ± SEM; n.s., non significant,*<i>P</i> < 0.05,**p < 0.01, ***p < 0.001, one-way ANOVA. …”
-
7
-
8
-
9
The decrease or inhibition of Hsp90 induced REST degradation.
Published 2019“…(E) The REST level decreased by GA more than 50% and (F) PU-H71 more than 80%, respectively. …”
-
10
-
11
-
12
-
13
-
14
Differences of SP concentration in CSF: diseased groups compared to the healthy control group. Legend: ↑↑ increased, p<0.05, ↑ increased, p>0.05 ↓↓ decreased, p<0.05 ↓ decreased, p>0.05 = no difference.
Published 2013“…Legend: ↑↑ increased, p<0.05, ↑ increased, p>0.05 ↓↓ decreased, p<0.05 ↓ decreased, p>0.05 = no difference.…”
-
15
Pre-treatment with CDDO-Me decreases IR-induced DNA damage in a variety of non-cancerous cells.
Published 2014“…Data analyzed and calculated using Open Comet software [tail moment = tail length x tail DNA percentage]. Mean ± SEM of >50 cells per condition, *p<0.05 using t-test (compared to 3 Gy DMSO). …”
-
16
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
17
-
18
-
19
-
20